id	sid	eid	entity	type
aji-33	102	1	asian journal of	ORG
aji-33	102	2	3(1	CARDINAL
aji-33	102	3	233	CARDINAL
aji-33	102	4	2020	DATE
aji-33	102	5	19	CARDINAL
aji-33	102	6	a. s.	PERSON
aji-33	103	1	1	CARDINAL
aji-33	103	2	gandhi institute of technology	ORG
aji-33	103	3	rishikonda	GPE
aji-33	103	4	visakhapatnam	GPE
aji-33	103	5	india	GPE
aji-33	105	1	1	CARDINAL
aji-33	105	2	cynthia	PERSON
aji-33	105	3	báez	ORG
aji-33	105	4	autonomous university of nuevo leon	ORG
aji-33	105	5	mexico	GPE
aji-33	106	1	1	CARDINAL
aji-33	106	2	ritika gupta	PERSON
aji-33	106	3	india	GPE
aji-33	107	1	2	CARDINAL
aji-33	107	2	adesoye idowu	ORG
aji-33	107	3	ilorin	NORP
aji-33	107	4	nigeria	GPE
aji-33	108	1	june 2020	DATE
aji-33	108	2	16	CARDINAL
aji-33	108	3	23	CARDINAL
aji-33	108	4	june 2020	DATE
aji-33	114	1	the3	ORG
aji-33	115	1	coagulative micro angiopathy	ORG
aji-33	117	1	prasad	ORG
aji-33	117	2	aji	ORG
aji-33	117	3	3(1	CARDINAL
aji-33	117	4	233	CARDINAL
aji-33	117	5	2020	DATE
aji-33	117	6	234	CARDINAL
aji-33	117	7	19	CARDINAL
aji-33	119	1	19	CARDINAL
aji-33	119	2	two	CARDINAL
aji-33	122	1	capillaritis	GPE
aji-33	124	1	2003	DATE
aji-33	124	2	2011	DATE
aji-33	125	1	34%	PERCENT
aji-33	125	2	middle east	LOC
aji-33	126	1	1	CARDINAL
aji-33	130	1	19	CARDINAL
aji-33	131	1	2	CARDINAL
aji-33	131	2	2.1	CARDINAL
aji-33	131	3	li	PERSON
aji-33	131	4	x.	GPE
aji-33	132	1	1	CARDINAL
aji-33	132	2	two	CARDINAL
aji-33	133	1	peter g gibson et al	PERSON
aji-33	133	2	2020	DATE
aji-33	134	1	2	CARDINAL
aji-33	134	2	covid-19	GPE
aji-33	135	1	wu c	PERSON
aji-33	135	2	chen x	PERSON
aji-33	135	3	cai y	PERSON
aji-33	135	4	xia j	PERSON
aji-33	135	5	zhou x	PERSON
aji-33	135	6	xu	PERSON
aji-33	135	7	2020	DATE
aji-33	136	1	20%	PERCENT
aji-33	136	2	about 3 to	CARDINAL
aji-33	137	1	~50%	PERCENT
aji-33	137	2	day 8	DATE
aji-33	138	1	5–10 days	DATE
aji-33	139	1	42%	PERCENT
aji-33	139	2	covid-19	PERSON
aji-33	139	3	61-81%	PERCENT
aji-33	140	1	3	CARDINAL
aji-33	141	1	covid-19	PERSON
aji-33	141	2	8.5 days	DATE
aji-33	141	3	singaporean	NORP
aji-33	142	1	4	CARDINAL
aji-33	142	2	19	CARDINAL
aji-33	143	1	ali	PERSON
aji-33	144	1	2 to 3%	PERCENT
aji-33	146	1	5–10 days	DATE
aji-33	147	1	19	CARDINAL
aji-33	149	1	2 to 3%	PERCENT
aji-33	151	1	peter g gibson et al	PERSON
aji-33	151	2	covid-19	PRODUCT
aji-33	151	3	berlin	GPE
aji-33	151	4	2012	DATE
aji-33	153	1	berlin	GPE
aji-33	153	2	aji	ORG
aji-33	153	3	3(1	CARDINAL
aji-33	153	4	233	CARDINAL
aji-33	153	5	2020	DATE
aji-33	153	6	235	CARDINAL
aji-33	153	7	1 week	DATE
aji-33	154	1	5	CARDINAL
aji-33	154	2	wang et al	PERSON
aji-33	155	1	6	CARDINAL
aji-33	155	2	8.0 days	DATE
aji-33	155	3	zhou et al	PERSON
aji-33	156	1	7	CARDINAL
aji-33	156	2	12 days	DATE
aji-33	157	1	chen et al	PERSON
aji-33	158	1	8	CARDINAL
aji-33	158	2	guan et al	PERSON
aji-33	159	1	9	CARDINAL
aji-33	160	1	4 days	DATE
aji-33	160	2	first	ORDINAL
aji-33	162	1	19	CARDINAL
aji-33	162	2	19	CARDINAL
aji-33	164	1	10	CARDINAL
aji-33	164	2	3	CARDINAL
aji-33	166	1	gattinoni et al	PERSON
aji-33	167	1	11	CARDINAL
aji-33	167	2	two	CARDINAL
aji-33	167	3	1	CARDINAL
aji-33	167	4	2	CARDINAL
aji-33	170	1	about 20% to 30%	PERCENT
aji-33	171	1	covid-19	PERSON
aji-33	172	1	2	CARDINAL
aji-33	172	2	secondary	ORDINAL
aji-33	172	3	1	CARDINAL
aji-33	172	4	2	CARDINAL
aji-33	174	1	3	CARDINAL
aji-33	175	1	4	CARDINAL
aji-33	175	2	dic	ORG
aji-33	176	1	2.2	CARDINAL
aji-33	176	2	about 97%	PERCENT
aji-33	176	3	5 days	DATE
aji-33	176	4	as early as 3 days	DATE
aji-33	176	5	56%	PERCENT
aji-33	176	6	2days	CARDINAL
aji-33	178	1	c. hani m.-p	PERSON
aji-33	180	1	2020	DATE
aji-33	180	2	19	CARDINAL
aji-33	180	3	12	CARDINAL
aji-33	183	1	1	CARDINAL
aji-33	183	2	50%	PERCENT
aji-33	184	1	2	CARDINAL
aji-33	185	1	3	CARDINAL
aji-33	186	1	4	CARDINAL
aji-33	187	1	1.	CARDINAL
aji-33	187	2	linear	ORG
aji-33	187	3	2	CARDINAL
aji-33	188	1	ggo	ORG
aji-33	188	2	88.0%	PERCENT
aji-33	188	3	31.8%	PERCENT
aji-33	188	4	87.5%	PERCENT
aji-33	188	5	76.0%	PERCENT
aji-33	188	6	13	CARDINAL
aji-33	189	1	guan cs	PERSON
aji-33	189	2	2020	DATE
aji-33	191	1	14	CARDINAL
aji-33	192	1	two	CARDINAL
aji-33	192	2	1	CARDINAL
aji-33	193	1	2	CARDINAL
aji-33	193	2	xu	PERSON
aji-33	193	3	l. shi	PERSON
aji-33	193	4	y. wang	PERSON
aji-33	194	1	15	CARDINAL
aji-33	197	1	prasad	ORG
aji-33	197	2	aji	ORG
aji-33	197	3	3(1	CARDINAL
aji-33	197	4	233	CARDINAL
aji-33	197	5	2020	DATE
aji-33	197	6	236	CARDINAL
aji-33	197	7	cd8+	ORG
aji-33	198	1	65	CARDINAL
aji-33	198	2	2	CARDINAL
aji-33	200	1	vascular	PERSON
aji-33	203	1	2.3	CARDINAL
aji-33	203	2	1	CARDINAL
aji-33	205	1	2	CARDINAL
aji-33	205	2	3	CARDINAL
aji-33	206	1	4	CARDINAL
aji-33	207	1	3	CARDINAL
aji-33	212	1	19	CARDINAL
aji-33	214	1	8+	DATE
aji-33	216	1	19	CARDINAL
aji-33	216	2	janusz jankowski	PERSON
aji-33	217	1	19	CARDINAL
aji-33	217	2	appendix 3	LAW
aji-33	217	3	4	CARDINAL
aji-33	221	1	2	CARDINAL
aji-33	221	2	four	CARDINAL
aji-33	221	3	2	CARDINAL
aji-33	221	4	2	CARDINAL
aji-33	222	1	2	CARDINAL
aji-33	222	2	19	CARDINAL
aji-33	222	3	nearly 200	CARDINAL
aji-33	224	1	hyderabad	GPE
aji-33	224	2	india	GPE
aji-33	224	3	a3i	GPE
aji-33	224	4	india	GPE
aji-33	224	5	maharashtra	NORP
aji-33	224	6	gujarat	GPE
aji-33	224	7	tamil	GPE
aji-33	224	8	delhi	GPE
aji-33	225	1	3 rd	DATE
aji-33	226	1	aji	ORG
aji-33	226	2	3(1	CARDINAL
aji-33	226	3	233	CARDINAL
aji-33	226	4	2020	DATE
aji-33	226	5	237	CARDINAL
aji-33	227	1	about 79%	PERCENT
aji-33	228	1	sofar	NORP
aji-33	228	2	appendix 1	FAC
aji-33	228	3	19	CARDINAL
aji-33	229	1	appendix 2	PRODUCT
aji-33	230	1	mhc	ORG
aji-33	230	2	2	CARDINAL
aji-33	233	1	19	CARDINAL
aji-33	234	1	19	CARDINAL
aji-33	235	1	a week or so	DATE
aji-33	235	2	first	ORDINAL
aji-33	236	1	a week or so	DATE
aji-33	242	1	4.1	CARDINAL
aji-33	242	2	4.1.1	CARDINAL
aji-33	242	3	joshua m. thurman	PERSON
aji-33	242	4	michael holers	PERSON
aji-33	243	1	16	CARDINAL
aji-33	243	2	1	CARDINAL
aji-33	244	1	17	CARDINAL
aji-33	245	1	2	CARDINAL
aji-33	245	2	c3	PERSON
aji-33	245	3	c3(h2o	ORG
aji-33	246	1	3	CARDINAL
aji-33	246	2	4	CARDINAL
aji-33	247	1	c3(h2o	ORG
aji-33	249	1	6	CARDINAL
aji-33	252	1	8	CARDINAL
aji-33	254	1	9	CARDINAL
aji-33	255	1	10	CARDINAL
aji-33	257	1	11	CARDINAL
aji-33	259	1	12	CARDINAL
aji-33	260	1	c5	ORG
aji-33	260	2	c5	ORG
aji-33	260	3	13	CARDINAL
aji-33	261	1	c6, c7	ORG
aji-33	265	1	prasad	NORP
aji-33	265	2	aji	ORG
aji-33	265	3	3(1	CARDINAL
aji-33	265	4	233	CARDINAL
aji-33	265	5	2020	DATE
aji-33	265	6	238	CARDINAL
aji-33	267	1	4.1.2	CARDINAL
aji-33	267	2	1	CARDINAL
aji-33	267	3	cd35	ORG
aji-33	267	4	daf	ORG
aji-33	267	5	cd55	ORG
aji-33	268	1	ic3b	LANGUAGE
aji-33	269	1	mcp	PERSON
aji-33	269	2	cd46	PRODUCT
aji-33	270	1	18	CARDINAL
aji-33	272	1	19	CARDINAL
aji-33	273	1	20	CARDINAL
aji-33	273	2	21	CARDINAL
aji-33	275	1	cfhr5	PERSON
aji-33	275	2	22	CARDINAL
aji-33	277	1	sazrscov2	ORG
aji-33	281	1	4.1.3	CARDINAL
aji-33	281	2	1	CARDINAL
aji-33	281	3	west nile	LOC
aji-33	281	4	two	CARDINAL
aji-33	281	5	c3	PERSON
aji-33	282	1	ic3b	NORP
aji-33	283	1	23	CARDINAL
aji-33	284	1	2	CARDINAL
aji-33	284	2	cd55	ORG
aji-33	284	3	cd59	ORG
aji-33	284	4	24,25	CARDINAL
aji-33	285	1	3	CARDINAL
aji-33	287	1	two	CARDINAL
aji-33	287	2	cd59	PRODUCT
aji-33	288	1	26	CARDINAL
aji-33	289	1	4	CARDINAL
aji-33	289	2	il-6	ORG
aji-33	289	3	marburg	PERSON
aji-33	290	1	27,28	CARDINAL
aji-33	291	1	5	CARDINAL
aji-33	291	2	31(hadv-31	CARDINAL
aji-33	293	1	third	ORDINAL
aji-33	294	1	c3	PERSON
aji-33	296	1	1	CARDINAL
aji-33	297	1	c3	PERSON
aji-33	299	1	2	CARDINAL
aji-33	299	2	αmβ2	ORG
aji-33	300	1	3	CARDINAL
aji-33	300	2	prasad	ORG
aji-33	300	3	aji	ORG
aji-33	300	4	3(1	CARDINAL
aji-33	300	5	233	CARDINAL
aji-33	300	6	2020	DATE
aji-33	300	7	239	CARDINAL
aji-33	304	1	19	CARDINAL
aji-33	305	1	one	CARDINAL
aji-33	306	1	secondly	ORDINAL
aji-33	309	1	19	CARDINAL
aji-33	309	2		CARDINAL
aji-33	309	3		CARDINAL
aji-33	309	4	135	CARDINAL
aji-33	312	1	xa	PERSON
aji-33	313	1	ecs	ORG
aji-33	313	2	tf	ORG
aji-33	315	1	xa	PERSON
aji-33	316	1	ecs	ORG
aji-33	316	2	tf	ORG
aji-33	317	1	tf	ORG
aji-33	318	1	megakaryocytes(indicating	DATE
aji-33	319	1	two	CARDINAL
aji-33	319	2	third	ORDINAL
aji-33	319	3	masp-19	DATE
aji-33	321	1	two	CARDINAL
aji-33	321	2	mblc4b2a3b	ORG
aji-33	322	1	cynthia magro	PERSON
aji-33	322	2	2020)of	CARDINAL
aji-33	322	3	c4d	PERSON
aji-33	324	1	aji	ORG
aji-33	324	2	3(1	CARDINAL
aji-33	324	3	233	CARDINAL
aji-33	324	4	2020	DATE
aji-33	324	5	1	CARDINAL
aji-33	325	1	2	CARDINAL
aji-33	326	1	3	CARDINAL
aji-33	327	1	4	CARDINAL
aji-33	327	2	1	CARDINAL
aji-33	327	3	29	CARDINAL
aji-33	328	1		CARDINAL
aji-33	329	1	alexander h. sprague	PERSON
aji-33	329	2	a. khalil et al	PERSON
aji-33	330	1	30	CARDINAL
aji-33	331	1	marlies van de	PERSON
aji-33	331	2	wouwer désiré colle	PERSON
aji-33	331	3	edward m. conway	PERSON
aji-33	332	1	31	CARDINAL
aji-33	335	1		CARDINAL
aji-33	336	1		CARDINAL
aji-33	336	2	ecs	ORG
aji-33	337	1		CARDINAL
aji-33	337	2	nf-κb	ORG
aji-33	337	3	smad	PERSON
aji-33	338	1		CARDINAL
aji-33	339	1		CARDINAL
aji-33	339	2	ecs	ORG
aji-33	339	3	angiotensin ii	PERSON
aji-33	340	1		CARDINAL
aji-33	340	2	ca2+	GPE
aji-33	340	3	vsm	PERSON
aji-33	342	1		CARDINAL
aji-33	342	2	il-1	GPE
aji-33	342	3	il6	GPE
aji-33	342	4	ifn-γ	PERSON
aji-33	342	5	mip-1β	PERSON
aji-33	342	6		CARDINAL
aji-33	344	1	ecm	ORG
aji-33	345	1		CARDINAL
aji-33	345	2	ecs	ORG
aji-33	345	3	smc proliferation	ORG
aji-33	346	1	cells;il-2	NORP
aji-33	346	2	il-5	PERSON
aji-33	346	3		CARDINAL
aji-33	346	4	ifn-γ	PERSON
aji-33	346	5		CARDINAL
aji-33	347	1	32	CARDINAL
aji-33	348	1	gmcsf	PERSON
aji-33	349	1	33	CARDINAL
aji-33	350	1		CARDINAL
aji-33	352	1	prasad	ORG
aji-33	352	2	aji	ORG
aji-33	352	3	3(1	CARDINAL
aji-33	352	4	233	CARDINAL
aji-33	352	5	2020	DATE
aji-33	352	6	241	CARDINAL
aji-33	352	7	monocyte	ORG
aji-33	352	8	34	CARDINAL
aji-33	354	1	35	CARDINAL
aji-33	357	1	von willebrand	PERSON
aji-33	357	2	thrombomodulin	GPE
aji-33	357	3	endothelin	GPE
aji-33	358	1	tnf	CARDINAL
aji-33	358	2	c3	PERSON
aji-33	358	3	36	CARDINAL
aji-33	359	1	37	CARDINAL
aji-33	359	2	38	CARDINAL
aji-33	360	1	39	CARDINAL
aji-33	361	1	40	CARDINAL
aji-33	363	1	41	CARDINAL
aji-33	372	1	tnfr1	PERSON
aji-33	374	1	tnfr1	PERSON
aji-33	375	1	1	CARDINAL
aji-33	375	2	cd35	ORG
aji-33	375	3	44	CARDINAL
aji-33	376	1	45,46	CARDINAL
aji-33	377	1	c3	PERSON
aji-33	377	2	c9	ORG
aji-33	377	3	47	CARDINAL
aji-33	378	1	48	CARDINAL
aji-33	378	2	49	CARDINAL
aji-33	379	1	ic3b	PRODUCT
aji-33	381	1	50	CARDINAL
aji-33	382	1	51	CARDINAL
aji-33	383	1	marlies van de wouwdésiré collen	PERSON
aji-33	383	2	edward m. conway	PERSON
aji-33	383	3	52	CARDINAL
aji-33	384	1	thrombomodulin	PERSON
aji-33	385	1	thrombomodulin	PERSON
aji-33	385	2	≈20	NORP
aji-33	385	3	aji	ORG
aji-33	385	4	3(1	CARDINAL
aji-33	385	5	233	CARDINAL
aji-33	385	6	2020	DATE
aji-33	386	1	4	CARDINAL
aji-33	386	2	apc	ORG
aji-33	387	1	apc	ORG
aji-33	387	2	apc	ORG
aji-33	388	1	apc	ORG
aji-33	388	2	1	CARDINAL
aji-33	390	1	apc	ORG
aji-33	391	1	apc	ORG
aji-33	392	1	thrombomodulin	PERSON
aji-33	394	1	von willebr	PERSON
aji-33	400	1	53	CARDINAL
aji-33	402	1	par4	ORG
aji-33	404	1	4.1.6.1	PRODUCT
aji-33	406	1	ifnγ	PERSON
aji-33	406	2	1	CARDINAL
aji-33	408	1	2	CARDINAL
aji-33	408	2	cd4 th1	PERSON
aji-33	408	3	ctl	ORG
aji-33	409	1		CARDINAL
aji-33	410	1		CARDINAL
aji-33	410	2	ii mhc molecules	PERSON
aji-33	411	1		CARDINAL
aji-33	411	2	mecl1	GPE
aji-33	412	1		CARDINAL
aji-33	412	2	il-1β	PERSON
aji-33	412	3	prasad	ORG
aji-33	412	4	aji	ORG
aji-33	412	5	3(1	CARDINAL
aji-33	412	6	233	CARDINAL
aji-33	412	7	2020	DATE
aji-33	412	8	article no.aji.58422 243	LAW
aji-33	413	1	ccl15	GPE
aji-33	413	2	cxcl8	PERSON
aji-33	414	1		CARDINAL
aji-33	414	2	19	CARDINAL
aji-33	415	1		CARDINAL
aji-33	416	1		CARDINAL
aji-33	417	1		CARDINAL
aji-33	417	2	igg2a	GPE
aji-33	417	3	igg3	GPE
aji-33	418	1		CARDINAL
aji-33	419	1		CARDINAL
aji-33	421	1	1	CARDINAL
aji-33	421	2	1	CARDINAL
aji-33	421	3	2(ifngr2	CARDINAL
aji-33	422	1	2	CARDINAL
aji-33	423	1	3	CARDINAL
aji-33	423	2	ifnγ	GPE
aji-33	424	1	4	CARDINAL
aji-33	425	1	th1	ORG
aji-33	426	1	1	CARDINAL
aji-33	427	1	1	CARDINAL
aji-33	430	1	2	CARDINAL
aji-33	430	2	protein-10	DATE
aji-33	430	3	th1	ORG
aji-33	432	1	3.	CARDINAL
aji-33	432	2	ifn-α1	PERSON
aji-33	432	3	hla-ii	PERSON
aji-33	433	1	4	CARDINAL
aji-33	433	2	hla-i	PERSON
aji-33	436	1	cd8+ t	ORG
aji-33	436	2	4+	DATE
aji-33	439	1	4+	CARDINAL
aji-33	440	1	ali ganji et al	PERSON
aji-33	441	1	53	CARDINAL
aji-33	441	2	cd8 mfi	ORG
aji-33	441	3	covid-19	GPE
aji-33	441	4	0.05	CARDINAL
aji-33	441	5	8+	DATE
aji-33	442	1	zheng et al	PERSON
aji-33	443	1	54	CARDINAL
aji-33	443	2	ctls	GPE
aji-33	444	1	covid-19	ORG
aji-33	445	1	nkg2a	ORG
aji-33	445	2	cd107a	ORG
aji-33	445	3	ifn-γ	PERSON
aji-33	447	1	nkg2a	ORG
aji-33	448	1		CARDINAL
aji-33	448	2	1	CARDINAL
aji-33	449	1	th1	ORG
aji-33	451	1	zcd4+cells	ORG
aji-33	452	1	2	CARDINAL
aji-33	452	2	il-5	PERSON
aji-33	456	1	3cb	ORDINAL
aji-33	456	2	3c	CARDINAL
aji-33	458	1	prasad	ORG
aji-33	458	2	aji	ORG
aji-33	458	3	3(1	CARDINAL
aji-33	458	4	233	CARDINAL
aji-33	458	5	2020	DATE
aji-33	458	6	244	CARDINAL
aji-33	458	7		CARDINAL
aji-33	458	8	1	CARDINAL
aji-33	459	1		CARDINAL
aji-33	461	1		CARDINAL
aji-33	461	2	igg mediated(through	GPE
aji-33	462	1	mediated,(through	PERSON
aji-33	464	1		CARDINAL
aji-33	464	2	2 molecules	QUANTITY
aji-33	467	1		CARDINAL
aji-33	467	2	il 4	PERSON
aji-33	467	3	il10	PRODUCT
aji-33	468	1		CARDINAL
aji-33	469	1		CARDINAL
aji-33	469	2	mac-1(surface	GPE
aji-33	471	1	il10	PRODUCT
aji-33	471	2	tgf	ORG
aji-33	473	1	tgf	ORG
aji-33	474	1		CARDINAL
aji-33	475	1		CARDINAL
aji-33	475	2	tgf	ORG
aji-33	475	3		CARDINAL
aji-33	476	1	1	CARDINAL
aji-33	477	1	two	CARDINAL
aji-33	477	2	m1 and m2	PRODUCT
aji-33	479	1	3	CARDINAL
aji-33	479	2	m2b	ORG
aji-33	480	1	3	CARDINAL
aji-33	480	2	1	CARDINAL
aji-33	480	3	1	CARDINAL
aji-33	481	1	2	CARDINAL
aji-33	482	1	3	CARDINAL
aji-33	482	2	4	CARDINAL
aji-33	482	3	tgf	ORG
aji-33	482	4	smad 2/3	PERSON
aji-33	482	5	5	CARDINAL
aji-33	482	6	6	CARDINAL
aji-33	483	1	ifn-γ	ORG
aji-33	483	2	7	CARDINAL
aji-33	483	3	8	CARDINAL
aji-33	485	1	9	CARDINAL
aji-33	486	1	10	CARDINAL
aji-33	486	2	7	CARDINAL
aji-33	487	1	prasad	ORG
aji-33	487	2	aji	ORG
aji-33	487	3	3(1	CARDINAL
aji-33	487	4	233	CARDINAL
aji-33	487	5	2020	DATE
aji-33	487	6	245	CARDINAL
aji-33	487	7	2	CARDINAL
aji-33	487	8	1	CARDINAL
aji-33	488	1	2	CARDINAL
aji-33	489	1	3	CARDINAL
aji-33	489	2	mmp-9	PERSON
aji-33	489	3	tgf	ORG
aji-33	490	1	4	CARDINAL
aji-33	491	1	5	CARDINAL
aji-33	491	2	pge2	ORG
aji-33	492	1	tgf	ORG
aji-33	493	1	3	CARDINAL
aji-33	494	1	1.lps 2	DATE
aji-33	495	1	th1	ORG
aji-33	495	2	ifn-γ	ORG
aji-33	495	3	il18	ORG
aji-33	495	4	3.gmcgo	CARDINAL
aji-33	495	5	ccl5 cxcl9	PERSON
aji-33	495	6	1.th2	CARDINAL
aji-33	495	7	il-5	PERSON
aji-33	495	8	2	CARDINAL
aji-33	496	1	2	CARDINAL
aji-33	498	1	3	CARDINAL
aji-33	498	2	4	CARDINAL
aji-33	498	3	il-1ra 5	DATE
aji-33	498	4	ccl22	ORG
aji-33	498	5	1	CARDINAL
aji-33	499	1	2	CARDINAL
aji-33	499	2	3.promotetissue	CARDINAL
aji-33	499	3	4.vasculogenesis 5	DATE
aji-33	500	1	1	CARDINAL
aji-33	500	2	mrc1	PERSON
aji-33	500	3	cd206	GPE
aji-33	500	4	2	CARDINAL
aji-33	500	5	mhc ii	PERSON
aji-33	500	6	systemof il-10	PERSON
aji-33	500	7	tgf	ORG
aji-33	501	1	lps il-1	PERSON
aji-33	501	2	tgf	ORG
aji-33	501	3	5	CARDINAL
aji-33	502	1	19	CARDINAL
aji-33	506	1	2	CARDINAL
aji-33	507	1	prasad	ORG
aji-33	507	2	aji	ORG
aji-33	507	3	3(1	CARDINAL
aji-33	507	4	233	CARDINAL
aji-33	507	5	2020	DATE
aji-33	507	6	246	CARDINAL
aji-33	510	1	leukocyteclasia	PERSON
aji-33	518	1	first	ORDINAL
aji-33	520	1	19	CARDINAL
aji-33	520	2	more than one	CARDINAL
aji-33	525	1	19	CARDINAL
aji-33	526	1	6	CARDINAL
aji-33	528	1	19	CARDINAL
aji-33	529	1	19	CARDINAL
aji-33	531	1	19	CARDINAL
aji-33	533	1	prasad	ORG
aji-33	533	2	aji	ORG
aji-33	533	3	3(1	CARDINAL
aji-33	533	4	233	CARDINAL
aji-33	533	5	2020	DATE
aji-33	533	6	247	CARDINAL
aji-33	536	1	1	CARDINAL
aji-33	536	2	li x	PERSON
aji-33	536	3	covid-19	DATE
aji-33	538	1	2020;24:198	CARDINAL
aji-33	539	1	2	CARDINAL
aji-33	539	2	peter g, gibson	PERSON
aji-33	539	3	ling qin	PERSON
aji-33	539	4	ser puah	PERSON
aji-33	540	1	covid-19	PERSON
aji-33	541	1	3.	CARDINAL
aji-33	541	2	wu	PERSON
aji-33	541	3	chen x	PERSON
aji-33	541	4	cai y	PERSON
aji-33	541	5	xia j	PERSON
aji-33	541	6	zhou x	PERSON
aji-33	541	7	xu s	PERSON
aji-33	541	8	huang h	PERSON
aji-33	541	9	zhang l	GPE
aji-33	541	10	zhou x	PERSON
aji-33	541	11	zhang y	PERSON
aji-33	541	12	wang s	PERSON
aji-33	541	13	chao y	PERSON
aji-33	541	14	yang z	PERSON
aji-33	541	15	xu j	PERSON
aji-33	541	16	zhou x	PERSON
aji-33	542	1	chen d	PERSON
aji-33	542	2	xiong w	PERSON
aji-33	543	1	zhou f	PERSON
aji-33	543	2	jiang j	PERSON
aji-33	543	3	bai c	PERSON
aji-33	543	4	zheng j	PERSON
aji-33	543	5	2019	CARDINAL
aji-33	543	6	wuhan	GPE
aji-33	543	7	china	GPE
aji-33	544	1	2020	DATE
aji-33	545	1	4	CARDINAL
aji-33	546	1	covid-19	PERSON
aji-33	548	1	ranieri vm	PERSON
aji-33	548	2	rubenfeld gd	PERSON
aji-33	549	1	berlin	GPE
aji-33	550	1	jama	PERSON
aji-33	551	1	2012;307	CARDINAL
aji-33	553	1	5	CARDINAL
aji-33	554	1	wang d	PERSON
aji-33	554	2	hu	PERSON
aji-33	554	3	hu	PERSON
aji-33	556	1	138	CARDINAL
aji-33	556	2	2019	CARDINAL
aji-33	556	3	wuhan	GPE
aji-33	556	4	china	GPE
aji-33	557	1	2020	DATE
aji-33	558	1	6	CARDINAL
aji-33	559	1	zhou f	PERSON
aji-33	559	2	yu t	PERSON
aji-33	560	1	covid-19	GPE
aji-33	560	2	wuhan	GPE
aji-33	560	3	china	GPE
aji-33	561	1	lancet	ORG
aji-33	561	2	2020	DATE
aji-33	562	1	huang c	PERSON
aji-33	562	2	wang y	PERSON
aji-33	562	3	li x	PERSON
aji-33	563	1	2019	CARDINAL
aji-33	563	2	wuhan	GPE
aji-33	563	3	china	GPE
aji-33	564	1	lancet	ORG
aji-33	566	1	8	CARDINAL
aji-33	567	1	guan wj	PERSON
aji-33	567	2	ni zy	PERSON
aji-33	568	1	2019	DATE
aji-33	568	2	china	GPE
aji-33	569	1	2020	DATE
aji-33	570	1	https://doi.org/10.1056/nejmoa2 002032 9	ORG
aji-33	571	1	robba c	PERSON
aji-33	573	1	2020	DATE
aji-33	574	1	10	CARDINAL
aji-33	574	2	rossi s.	PERSON
aji-33	576	1	2020;24:154	CARDINAL
aji-33	577	1	11	CARDINAL
aji-33	578	1	xiaowei li	PERSON
aji-33	578	2	shemin lu	PERSON
aji-33	579	1	covid-19	ORG
aji-33	580	1	2020	DATE
aji-33	580	2	10(2):102-108	CARDINAL
aji-33	581	1	12	CARDINAL
aji-33	582	1	chani mp	PERSON
aji-33	584	1	2020;101(5):263-268	CARDINAL
aji-33	585	1	13	CARDINAL
aji-33	586	1	shi h	PERSON
aji-33	586	2	han x	PERSON
aji-33	586	3	jiang n.	PERSON
aji-33	586	4	81	CARDINAL
aji-33	586	5	covid-19	ORG
aji-33	586	6	wuhan	GPE
aji-33	586	7	china	GPE
aji-33	587	1	lancet	ORG
aji-33	588	1	2020;20:425–434	CARDINAL
aji-33	589	1	14	DATE
aji-33	590	1	wei-jie guan	PERSON
aji-33	590	2	china	GPE
aji-33	590	3	2020	DATE
aji-33	591	1	xu zhe	PERSON
aji-33	591	2	lei shi	PERSON
aji-33	591	3	yijin wang	PERSON
aji-33	591	4	jiyuan zhang	PERSON
aji-33	591	5	lei huang	PERSON
aji-33	591	6	chao zhang	PERSON
aji-33	591	7	shuhong liu	PERSON
aji-33	592	1	covid-19	ORG
aji-33	594	1	2020;8(4):420	CARDINAL
aji-33	595	1	16	CARDINAL
aji-33	596	1	joshua m. thurman	PERSON
aji-33	596	2	michael holers	PERSON
aji-33	597	1	j immunol	PERSON
aji-33	600	1	nilsson b	ORG
aji-33	600	2	nilsson ekdahl k.	ORG
aji-33	601	1	c3	PERSON
aji-33	603	1	2012;217(11	CARDINAL
aji-33	603	2	1106‐1110	DATE
aji-33	604	1	18	CARDINAL
aji-33	604	2	j. assembly	PERSON
aji-33	605	1	curr	PERSON
aji-33	606	1	opin	GPE
aji-33	608	1	1991;3(4	DATE
aji-33	608	2	710–716	CARDINAL
aji-33	609	1	19	CARDINAL
aji-33	610	1	conrad dh	PERSON
aji-33	610	2	carlo jr	PERSON
aji-33	610	3	ruddy s. interaction	PERSON
aji-33	612	1	1978	DATE
aji-33	612	2	147(6):1792–1805	CARDINAL
aji-33	612	3	20	CARDINAL
aji-33	613	1	weiler jm	PERSON
aji-33	613	2	austen kf	PERSON
aji-33	613	3	fearon	ORG
aji-33	615	1	the national academy of sciences	ORG
aji-33	615	2	the united states of america	GPE
aji-33	617	1	21	CARDINAL
aji-33	618	1	schreiber rd	PERSON
aji-33	618	2	müllereberhard hj	PERSON
aji-33	619	1	prasad	ORG
aji-33	619	2	aji	ORG
aji-33	619	3	3(1	CARDINAL
aji-33	619	4	233	CARDINAL
aji-33	619	5	2020	DATE
aji-33	619	6	248	CARDINAL
aji-33	621	1	1977;146(1):257	CARDINAL
aji-33	621	2	70	CARDINAL
aji-33	623	1	mcrae jl	PERSON
aji-33	623	2	duthy tg	PERSON
aji-33	623	3	griggs km	PERSON
aji-33	623	4	ormsby rj	PERSON
aji-33	623	5	cowan pj	PERSON
aji-33	623	6	cromer ba	PERSON
aji-33	623	7	mckinstry wj	PERSON
aji-33	623	8	parker mw	PERSON
aji-33	623	9	murphy	PERSON
aji-33	623	10	gordon dl	PERSON
aji-33	623	11	5	CARDINAL
aji-33	623	12	c3	PERSON
aji-33	625	1	2005;174(10	CARDINAL
aji-33	625	2	6250–6	CARDINAL
aji-33	625	3	23	CARDINAL
aji-33	626	1	butthep p	ORG
aji-33	627	1	southeast asian	NORP
aji-33	627	2	j. trop	PERSON
aji-33	630	1	1):246–249	CARDINAL
aji-33	631	1	24	CARDINAL
aji-33	631	2	avirutnan p	GPE
aji-33	631	3	fuchs	ORG
aji-33	631	4	hauhart	ORG
aji-33	631	5	somnuke p	PERSON
aji-33	631	6	youn s	ORG
aji-33	631	7	atkinson jp	PERSON
aji-33	633	1	j. exp	PERSON
aji-33	633	2	2010;207:793–806	CARDINAL
aji-33	633	3	25	CARDINAL
aji-33	634	1	saifuddin m	PERSON
aji-33	634	2	parker cj	PERSON
aji-33	634	3	gorny mk	PERSON
aji-33	634	4	rooney ia	PERSON
aji-33	634	5	atkinson jp	PERSON
aji-33	635	1	cd55	ORG
aji-33	635	2	cd59	ORG
aji-33	636	1	j. exp	PERSON
aji-33	638	1	26	CARDINAL
aji-33	638	2	lurain ns	PERSON
aji-33	638	3	parker cj	PERSON
aji-33	638	4	payne gh	PERSON
aji-33	638	5	saifuddin m.	PERSON
aji-33	638	6	cd55	ORG
aji-33	638	7	cd59	ORG
aji-33	638	8	two	CARDINAL
aji-33	639	1	j. immunol	PERSON
aji-33	640	1	4376–4381	CARDINAL
aji-33	641	1	27	CARDINAL
aji-33	642	1	datta pk	PERSON
aji-33	644	1	pharmacother	PERSON
aji-33	645	1	2006;60	CARDINAL
aji-33	646	1	561–568	CARDINAL
aji-33	646	2	28	CARDINAL
aji-33	647	1	butthep p	ORG
aji-33	647	2	granulocytopenia	GPE
aji-33	648	1	southeast asian	NORP
aji-33	648	2	j. trop	PERSON
aji-33	650	1	1	CARDINAL
aji-33	651	1	29	CARDINAL
aji-33	652	1	van dam-mieras mc	PERSON
aji-33	652	2	van hinsbergh vw	PERSON
aji-33	652	3	mullers wj	PERSON
aji-33	652	4	bomans	NORP
aji-33	655	1	haemost	PERSON
aji-33	656	1	1992;68:364–370	CARDINAL
aji-33	657	1	30	CARDINAL
aji-33	658	1	renne t.	PERSON
aji-33	659	1	semin	PERSON
aji-33	663	1	alexander h. sprague	PERSON
aji-33	663	2	a. khalil	PERSON
aji-33	665	1	biochem pharmacol	ORG
aji-33	666	1	2009;78(6):539	CARDINAL
aji-33	666	2	552	CARDINAL
aji-33	666	3	32	CARDINAL
aji-33	667	1	marlies van de	PERSON
aji-33	667	2	wouwer désiré colle	PERSON
aji-33	667	3	edward m. conway	PERSON
aji-33	668	1	2004	DATE
aji-33	669	1	24:1374–138	DATE
aji-33	670	1	33	DATE
aji-33	671	1	muzio m	PERSON
aji-33	671	2	stockwell	ORG
aji-33	671	3	salvesen gs	PERSON
aji-33	671	4	dixit vm	ORG
aji-33	674	1	1998;273(5):2926–2930	CARDINAL
aji-33	675	1	34	CARDINAL
aji-33	676	1	yoshizumi m	PERSON
aji-33	676	2	perrella ma	PERSON
aji-33	676	3	burnett jc	PERSON
aji-33	676	4	lee	PERSON
aji-33	677	1	half	CARDINAL
aji-33	679	1	1993;73(1):205–209	CARDINAL
aji-33	680	1	35	CARDINAL
aji-33	681	1	meacci e	PERSON
aji-33	681	2	perrotta c	ORG
aji-33	681	3	bruni p	ORG
aji-33	681	4	clementi e. endothelial	PERSON
aji-33	681	5	2	CARDINAL
aji-33	681	6	1	CARDINAL
aji-33	681	7	1	CARDINAL
aji-33	684	1	36	CARDINAL
aji-33	685	1	j. sweet	PERSON
aji-33	687	1	2007;102:9–1136	CARDINAL
aji-33	688	1	liu j	PERSON
aji-33	688	2	c5ar	ORG
aji-33	690	1	2015;62:354–362	CARDINAL
aji-33	691	1	10.1016	CARDINAL
aji-33	691	2	j. 37	ORG
aji-33	692	1	yamagishi	ORG
aji-33	694	1	2009;32	CARDINAL
aji-33	695	1	10.1002	CARDINAL
aji-33	696	1	yang g	PERSON
aji-33	696	2	shao	PERSON
aji-33	696	3	neurol sci	PERSON
aji-33	697	1	2016;37:1253–1259	CARDINAL
aji-33	698	1	39	CARDINAL
aji-33	699	1	zhang h	PERSON
aji-33	700	1	clin sci	PERSON
aji-33	700	2	2009	DATE
aji-33	701	1	aji	ORG
aji-33	701	2	3(1	CARDINAL
aji-33	701	3	233	CARDINAL
aji-33	701	4	2020	DATE
aji-33	701	5	249 40	DATE
aji-33	704	1	ciba	ORG
aji-33	704	2	symp	PERSON
aji-33	705	1	1987	DATE
aji-33	706	1	131:170–184	CARDINAL
aji-33	707	1	41	CARDINAL
aji-33	708	1	zelová h	ORG
aji-33	708	2	j. tnf	PERSON
aji-33	709	1	inflamm	ORG
aji-33	711	1	641–651	CARDINAL
aji-33	711	2	palikaras k	PERSON
aji-33	712	1	biophys acta	PERSON
aji-33	713	1	2013	DATE
aji-33	713	2	1833:3448–3459	CARDINAL
aji-33	714	1	42	CARDINAL
aji-33	715	1	pignatelli p	PERSON
aji-33	717	1	2005	DATE
aji-33	717	2	106:1992–1994	CARDINAL
aji-33	718	1	10.1182/	MONEY
aji-33	719	1	pignatelli p	PERSON
aji-33	721	1	cardiovasc	ORG
aji-33	723	1	44	DATE
aji-33	724	1	lapin zj	PERSON
aji-33	724	2	novotny l.	PERSON
aji-33	724	3	1	CARDINAL
aji-33	724	4	cr1/cd35	ORG
aji-33	725	1	j neuroimmune pharmacol	PERSON
aji-33	726	1	2012;7:539	CARDINAL
aji-33	726	2	543	CARDINAL
aji-33	726	3	45	CARDINAL
aji-33	727	1	pascual m	PERSON
aji-33	728	1	1	CARDINAL
aji-33	730	1	46	DATE
aji-33	731	1	zeerleder s. methods for	PERSON
aji-33	732	1	j vis exp	PERSON
aji-33	732	2	2014	DATE
aji-33	732	3	47	DATE
aji-33	733	1	patzelt j	PERSON
aji-33	733	2	langer hf	PERSON
aji-33	736	1	2015;6:49	CARDINAL
aji-33	737	1	10.3389	CARDINAL
aji-33	737	2	48	DATE
aji-33	738	1	hamad oa	PERSON
aji-33	740	1	j thromb haemost	PERSON
aji-33	741	1	49	CARDINAL
aji-33	742	1	martel	PERSON
aji-33	743	1	plos one	PERSON
aji-33	744	1	2011;6	CARDINAL
aji-33	744	2	10.1371	CARDINAL
aji-33	745	1	50	CARDINAL
aji-33	746	1	del conde	PERSON
aji-33	746	2	cruz ma	PERSON
aji-33	746	3	zhang h	PERSON
aji-33	746	4	lopez ja	PERSON
aji-33	746	5	afshar-kharghan	PERSON
aji-33	747	1	2005	DATE
aji-33	748	1	10.1084/jem.20041497 51	MONEY
aji-33	751	1	nat immunol	PERSON
aji-33	752	1	2011;12:1194–1201	CARDINAL
aji-33	753	1	52	DATE
aji-33	754	1	marlies van de wouwer désiré collen	PERSON
aji-33	754	2	edward m. conway thrombomodulinprotein	PERSON
aji-33	757	1	2004;24:1374–13838	CARDINAL
aji-33	757	2	kurosawa s	PERSON
aji-33	757	3	mollica	PERSON
aji-33	757	4	ferrell gl	PERSON
aji-33	759	1	sci usa. 1996	ORG
aji-33	759	2	10216	DATE
aji-33	760	1	53	DATE
aji-33	760	2	ali ganji	PERSON
aji-33	760	3	covid-19	GPE
aji-33	760	4	2020	DATE
aji-33	762	1	zheng et al	PERSON
aji-33	763	1	covid-19	GPE
aji-33	764	1	2020	DATE
aji-33	765	1	aji	ORG
aji-33	765	2	3(1	CARDINAL
aji-33	765	3	233	CARDINAL
aji-33	765	4	2020	DATE
aji-33	765	5	250	CARDINAL
aji-33	765	6	1	CARDINAL
aji-33	765	7	1	CARDINAL
aji-33	766	1	2	CARDINAL
aji-33	767	1	3	CARDINAL
aji-33	768	1	4.toll	CARDINAL
aji-33	769	1	5	CARDINAL
aji-33	769	2	cd14	PRODUCT
aji-33	769	3	four	CARDINAL
aji-33	769	4	1	CARDINAL
aji-33	769	5	2	CARDINAL
aji-33	769	6	3	CARDINAL
aji-33	769	7	rlr	ORG
aji-33	769	8	4	CARDINAL
aji-33	770	1	1	CARDINAL
aji-33	770	2	lipoglycans	NORP
aji-33	770	3	2	CARDINAL
aji-33	770	4	appendix 2	PERSON
aji-33	770	5	1	CARDINAL
aji-33	771	1	2	CARDINAL
aji-33	772	1	1.	CARDINAL
aji-33	773	1	1	CARDINAL
aji-33	773	2	2	CARDINAL
aji-33	773	3	mapk	ORG
aji-33	773	4	3	CARDINAL
aji-33	773	5	ikkβ	GPE
aji-33	774	1	3	CARDINAL
aji-33	775	1	3 and 7	PERCENT
aji-33	775	2	4.these	CARDINAL
aji-33	775	3	1.type	CARDINAL
aji-33	775	4	prasad	ORG
aji-33	775	5	aji	ORG
aji-33	775	6	3(1	CARDINAL
aji-33	775	7	233	CARDINAL
aji-33	775	8	2020	DATE
aji-33	775	9	251	CARDINAL
aji-33	776	1	esr crp	PERSON
aji-33	778	1	ac mi	PERSON
aji-33	782	1	leucopenia	PERSON
aji-33	784	1	secondary	ORDINAL
aji-33	784	2	appendix 4	PERSON
aji-33	784	3	1	CARDINAL
aji-33	786	1	1	CARDINAL
aji-33	786	2	cd16	PRODUCT
aji-33	787	1	2	CARDINAL
aji-33	787	2	igg	ORG
aji-33	788	1	3	CARDINAL
aji-33	788	2	nk	ORG
aji-33	789	1	2	CARDINAL
aji-33	789	2	mait cells	ORG
aji-33	790	1	ait	ORG
aji-33	793	1	3	CARDINAL
aji-33	796	1	4	CARDINAL
aji-33	796	2	prasad	ORG
aji-33	796	3	aji	ORG
aji-33	796	4	3(1	CARDINAL
aji-33	796	5	233	CARDINAL
aji-33	796	6	2020	DATE
aji-33	796	7	252 5	DATE
aji-33	797	1	1	CARDINAL
aji-33	797	2	2	CARDINAL
aji-33	798	1	3	CARDINAL
aji-33	799	1	4	CARDINAL
aji-33	799	2	ifn-γ	ORG
aji-33	800	1	6	CARDINAL
aji-33	802	1	1	CARDINAL
aji-33	802	2	2	CARDINAL
aji-33	885	1	2020	CARDINAL